SCHEMBL200096

SCHEMBL200096

CCCCCCCCCCCCSCCCC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.54
THRB P10828 2/20 0.54
HSD17B10 Q99714 2/20 0.54
GMNN O75496 1/20 0.54
TP53 P04637 1/20 0.54
POLB P06746 1/20 0.54
MAPT P10636 1/20 0.54
CYP2C9 P11712 1/20 0.54
BLM P54132 1/20 0.54
TSHR P16473 2/20 0.53
CA2 P00918 1/20 0.52
FAAH O00519 4/20 0.46
CES1 P23141 4/20 0.46
PLA2G6 O60733 1/20 0.46
CTSL P07711 1/20 0.42
CTSB P07858 1/20 0.42
PRKD3 O94806 2/20 0.42
PRKCG P05129 2/20 0.42
PRKCB P05771 2/20 0.42
PRKCA P17252 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL198596 1.00 CES2 (0.54) CES2THRBHSD17B10GMNNTP53
SCHEMBL200628 1.00 CES2 (0.54) CES2THRBHSD17B10GMNNTP53
SCHEMBL9862442 1.00 CES2 (0.54) CES2THRBHSD17B10GMNNTP53
SCHEMBL199887 1.00 CES2 (0.54) CES2THRBHSD17B10GMNNTP53
SCHEMBL198802 1.00 CES2 (0.54) CES2THRBHSD17B10GMNNTP53
Dioctylsulfane SCHEMBL1358875 1.00 CES2 (0.54) CES2THRBHSD17B10GMNNTP53
SCHEMBL23034315 1.00 CES2 (0.54) CES2THRBHSD17B10GMNNTP53
SCHEMBL9231864 1.00 CES2 (0.54) CES2THRBHSD17B10GMNNTP53
SCHEMBL7153602 1.00 CES2 (0.54) CES2THRBHSD17B10GMNNTP53
SCHEMBL201823 1.00 CES2 (0.54) CES2THRBHSD17B10GMNNTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4456900-A1 RESPIRATORY STIMULANT PARENTERAL FORMULATIONS Enalare Therapeutics Inc. (US) 2024-11-06 EP disclosed
CN-112533934-B Polyoxometallate compounds exhibiting bright emissions and methods of making same 纳米2D材料有限公司 2024-07-19 CN disclosed
CN-117083818-A Optical transmission system, optical transmission path, and photoelectric composite cable 小池康博 2023-11-17 CN disclosed
WO-2023129502-A1 RESPIRATORY STIMULANT PARENTERAL FORMULATIONS ENALARE THERAPEUTICS INC. (US) 2023-07-06 WO disclosed
WO-2023041690-A1 STABILIZER FORMULATION BASF SE (DE) 2023-03-23 WO disclosed
EP-4126810-A1 USE OF SUBSTITUTED CINNAMIC ACID ESTERS AS STABILISERS FOR ORGANIC MATERIALS, STABILISED ORGANIC MATERIAL, METHOD FOR STABILISING ORGANIC MATERIALS AND SPECIFIC CINAMIC ACID ESTERS Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2023-02-08 EP disclosed
US-20220162422-A1 METHOD FOR STABILIZING THERMOPLASTIC RECYCLATES, STABILIZED PLASTIC COMPOSITIONS, AND MOLDING COMPOUNDS AND MOLDED PARTS PRODUCED THEREFROM Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. (DE) 2022-05-26 US disclosed
EP-3941970-A1 UV CURABLE COMPOSITIONS FOR DIRT PICK-UP RESISTANCE BASF SE (DE) 2022-01-26 EP disclosed
US-11192908-B2 Octamolybdate compounds exhibiting bright emission NANOCO 2D MATERIALS LIMITED (GB) 2021-12-07 US disclosed
CN-113166470-A Method for stabilizing virgin thermoplastic materials and stabilized plastic compositions, molding compounds and moldings produced therefrom, stabilizer composition and use thereof 弗劳恩霍夫应用研究促进协会 2021-07-23 CN disclosed
CN-1011765-B PROCESS FOR FOAM FLOTATION OF S-CONTG. ORE DOW CHEMICAL CO (US) 1991-02-27 CN disclosed
EP-0240462-B1 SUBSTITUTED AMINOOXYPROPANOATE CIBA-GEIGY AG (CH) 1990-08-01 EP disclosed
US-4702822-A ORGANIC SULFIDE WITH ALKYL THIOCARBONATE, THIONACARBAMATEA, OR THIOPHOSPHATE THE DOW CHEMICAL COMPANY (US) 1987-10-27 US disclosed
US-4676890-A MIXTURE OF THIOALKYL AMINE AND HYDROCARBYL SULFIDES; SULFIDE ORES; PREFERENTIAL THE DOW CHEMICAL COMPANY (US) 1987-06-30 US disclosed
WO-1987003222-A1 COLLECTOR COMPOSITIONS FOR THE FROTH FLOTATION OF MINERAL VALUES THE DOW CHEMICAL COMPANY (US) 1987-06-04 WO disclosed
CN-86101495-A The collector composition that is used for the pneumatic flotation of mineral effective constituent 1987-06-03 CN disclosed
WO-1987000451-A1 NOVEL COLLECTOR COMPOSITION FOR FROTH FLOTATION THE DOW CHEMICAL COMPANY (US) 1987-01-29 WO disclosed
CN-86101682-A Be used for sulfide mineral and select the new collector of pneumatic flotation 1987-01-28 CN disclosed
EP-0206413-A2 Stabilized polymeric compositions and stabilizer systems suitable to this purpose BOZZETTO INDUSTRIE CHIMICHE S.p.A. (IT) 1986-12-30 EP disclosed
WO-1986006983-A1 NOVEL COLLECTORS FOR THE SELECTIVE FROTH FLOTATION OF SULFIDE MINERALS THE DOW CHEMICAL COMPANY (US) 1986-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192908-B2 Octamolybdate compounds exhibiting bright emission KCNN4, PUF60, OCIAD1 CES2 4313/4885THRB 2281/4885HSD17B10 3542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.